Pattern of demyelination occurring during anti-TNF-α therapy: A french national survey

Rheumatology (United Kingdom)

Volumn 52, Issue 5, 2013, Pages 868-874

  Seror, Raphaèle ^a   Richez, Christophe ^b   Sordet, Christelle ^c   Rist, Stéphanie ^d   Gossec, Laure ^e   Direz, Guillaume ^f   Houvenagel, Eric ^g   Berthelot, Jean Marie ^h   Pagnoux, Christian ^e   Dernis, Emmanuelle ⁱ   Melac Ducamp, Sylvie ^j   Bouvard, Beatrice ^k   Asquier, Caroline ^l   Martin, Antoine ^m   Puechal, Xavier ⁱ   Mariette, Xavier ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^e université Paris Cité   (France)

^f UNIVERSITÉ DE TOURS   (France)

^g Centre Hospitalier Saint Philibert GHICL   (France)

^h HÔTEL DIEU   (France)

ⁱ Le Mans General Hospital   (France)

^j General Hospital of Nevers   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l Service de Soins de Longue Duree   (France)

^m Centre Hospitalier de Saint Brieuc   (France)

more..

Author keywords

Anti TNF ; CIDP; Demyelinating; Multiple sclerosis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BETA INTERFERON; CLOBAZAM; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; INTERFERON; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADOLESCENT; ADULT; AGED; AMNESIA; ANESTHESIA; ANKYLOSING SPONDYLITIS; AREFLEXIA; ARTICLE; ATAXIA; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CEREBELLAR ATAXIA; CEREBELLUM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CLINICAL ARTICLE; COLOR VISION DEFECT; CONFUSION; DEMYELINATING DISEASE; DIPLOPIA; DISTAL HYPOPALLESTHESIA; DIZZINESS; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSARTHRIA; DYSPHASIA; ENCEPHALIC LESION; EYE PAIN; FALLING; FEMALE; GUILLAIN BARRE SYNDROME; HEADACHE; HEMIANESTHESIA; HEMIPARESIS; HUMAN; HYPERALGESIA; HYPESTHESIA; JUVENILE RHEUMATOID ARTHRITIS; LHERMITTE SIGN; LIMB WEAKNESS; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYELITIS; NERVE CONDUCTION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARAPLEGIA; PARESTHESIA; PERIPHERAL NERVOUS SYSTEM; PLEOCYTOSIS; POLYMYOSITIS; POLYRADICULONEUROPATHY; POSTERIOR CORDONAL SYNDROME; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSORIATIC ARTHRITIS; PYRAMIDAL SIGN; RELAPSE; RHEUMATOID ARTHRITIS; SEIZURE; SENSORY DYSFUNCTION; SENSORY MOTOR DEFICIT; SIDE EFFECT; SPONDYLOARTHROPATHY; STEROID THERAPY; TREATMENT RESPONSE; VERTIGO; VISUAL IMPAIRMENT; WALKING DIFFICULTY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DEMYELINATING DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUESTIONNAIRES; RECEPTORS, TUMOR NECROSIS FACTOR; RHEUMATOLOGY; RISK ASSESSMENT; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84876722379     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes375     Document Type: Article

References (17)

1. Mohan N, Edwards ET, Cupps TR et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001; 44: 2862-9.
2. The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999; 53: 457-65.
3. van Oosten BW, Barkhof F, Truyen L et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996; 47: 1531-4.
4. Richez C, Blanco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 2005; 64: 1468-70.
5. Jarand J, Zochodne DW, Martin LO, Voll C. Neurological complications of infliximab. J Rheumatol 2006; 33: 1018-20.
6. Rodriguez-Escalera C, Belzunegui J, Lopez-Dominguez L, Gonzalez C, Figueroa M. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology 2005; 44: 132-3.
7. Singer OC, Otto B, Steinmetz H, Ziemann U. Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy. Neurology 2004; 63: 1754.
8. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
9. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005; 58: 840-6.
10. Antoine JC, Azulay JP, Bouche P et al. [Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic strategy. Guidelines of the French CIDP study group]. Rev Neurol 2005; 161: 988-96.
11. Hughes RA, Bouche P, Cornblath DR et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006; 13: 326-32.
12. Bensouda-Grimaldi L, Mulleman D, Valat JP, Autret-Leca E. Adalimumab-associated multiple sclerosis. J Rheumatol 2007; 34: 239-40; discussion 240.
13. Debouverie M, Pittion-Vouyovitch S, Louis S, Roederer T, Guillemin F. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler 2007; 13: 962-7.
14. Viala K. [Epidemiological and clinical aspects of CIDP]. Rev Neurol 2007; 163(Spec No. 1): 3S31-5.
15. Tubach F, Salmon-Ceron D, Ravaud P, Mariette X. The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapy. Joint Bone Spine 2005; 72: 456-60.
16. Toussirot E, Pertuiset E, Martin A et al. Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance. J Rheumatol 2006; 33: 1027-8.
17. Ramos-Casals M, Roberto Perez A, Diaz-Lagares C, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 2010; 9: 188-93.